
Vysis ALK Break Apart FISH Probe Kit: Driven by FISH technology
Vysis ALK is a FISH-based (fluorescence in situ hybridization) test. FISH has been widely studied, validated, and utilized as an aid in the diagnosis of multiple types of cancer, including lung cancer.
As a FISH test, Vysis ALK uses two probes to reveal all ALK gene rearrangements for non-small cell lung cancer patients.
Intended Use
The Vysis ALK Break Apart FISH Probe Kit is a qualitative test to detect rearrangements involving the ALK gene via fluorescence in situ hybridization (FISH) in formalin-fixed paraffin-embedded (FFPE) non-small cell lung cancer (NSCLC) tissue specimens to aid in identifying those patients eligible for treatment with XALKORI® (crizotinib).
The test is for prescription use only.
Limitations of the Procedure
- The Vysis ALK Break Apart FISH Probe Kit has been optimized only for identifying and quantifying rearrangements of the ALK gene from formalin-fixed, paraffin-embedded human NSCLC tissue specimens. The assay should be performed only on 10% neutral buffered formalin FFPE human lung cancer tissue. Other types of specimens or fixatives should not be used.
FOR IN VITRO DIAGNOSTIC USE ONLY
Additional Important Safety Information about Vysis ALK |